Tools
Tools
Varney, A.M., Smitten, K.L., Thomas, J.A. and McLean, S. 
ORCID: 0000-0001-8551-4307,
2020.
Transcriptomic analysis of the activity and mechanism of action of a ruthenium(II)-based antimicrobial that induces minimal evolution of pathogen resistance.
ACS Pharmacology & Translational Science.
ISSN 2575-9108
|
Text
1389976_McLean.pdf - Accepted version Download (2MB) | Preview |
Abstract
Increasing concern over the rising levels of antibiotic resistance amongst pathogenic bacteria has prompted significant research to develop efficacious alternatives to antibiotic treatment. Previously we have reported on the therapeutic activity of a dinuclear ruthenium (II) complex against pathogenic, multidrug resistant bacterial pathogens. Herein, we report that the solubility properties of this lead are comparable to those exhibited by orally available therapeutics, that - in comparison to clinically relevant antibiotics - it induces very slow evolution of resistance in the uropathogenic, therapeutically resistant, E. coli strain EC958 and this resistance was lost when exposure to the compound was temporarily removed. With the aim of further investigating the mechanism of action of this compound, the regulation of nine target genes relating to the membrane, DNA damage and other stress responses provoked by exposure to the compound was also studied. This analysis confirmed that the compound causes a significant transcriptional downregulation of genes involved in membrane transport and the tricarboxylic acid cycle. By contrast, expression of the chaperone protein-coding gene, spy, was significantly increased suggesting a requirement for repair of damaged proteins in the region of the outer membrane. The complex was also found to display activity comparable to that in E. coli in a range of other therapeutically relevant Gram-negative pathogens.
| Item Type: | Journal article | ||||||
|---|---|---|---|---|---|---|---|
| Alternative Title: | A transcriptomic analysis of the activity and mechanism of action of a ruthenium(II)-based antimicrobial that induces minimal evolution of pathogen resistance | ||||||
| Publication Title: | ACS Pharmacology & Translational Science | ||||||
| Creators: | Varney, A.M., Smitten, K.L., Thomas, J.A. and McLean, S. | ||||||
| Publisher: | ACS Publications | ||||||
| Date: | 8 December 2020 | ||||||
| ISSN: | 2575-9108 | ||||||
| Identifiers: |
|
||||||
| Divisions: | Schools > School of Science and Technology | ||||||
| Record created by: | Linda Sullivan | ||||||
| Date Added: | 23 Nov 2020 10:13 | ||||||
| Last Modified: | 08 Dec 2021 03:00 | ||||||
| URI: | https://irep.ntu.ac.uk/id/eprint/41676 |
Actions (login required)
 |
Edit View |
Views
Views per month over past year
Downloads
Downloads per month over past year
